TMO Thermo Fisher Scientific Inc.

HealthcareMedical - Diagnostics & Research
$474.34
0.29%
47
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
47
Short-Term
47

Value

48
P/E25.73
52
P/B3.40
46
P/S3.90
52
EV/EBITDA19.37
43

Growth

41
Revenue Growth3.9%
38
EPS Growth7.2%
44
FCF Growth-13.4%
43

Momentum

47
12-Month Return16.6%
59
3-Month Return-12.5%
40
1-Month Return-5.7%
43
RSI (14)26.80
60
50/200 MABearish
30

Profitability

45
ROE13.3%
54
ROA6.1%
43
Gross Margin39.4%
39
Operating Margin17.8%
46
Net Margin15.2%
50
FCF Yield3.8%
38

Risk

52
Beta0.88
75
60-Day Volatility33.6%
33

Generated 5/7/2026, 7:12:31 PM · How is this calculated?

QScore Analysis

The QScore of 47 for Thermo Fisher Scientific indicates a neutral outlook, with the stock's long-term and short-term scores converging. The stock scores relatively high on value and risk factors, but is dragged down by lower growth and momentum scores, with revenue growth of 3.9% and a 12-month return of 16.6% offset by a recent 3-month decline of 12.5%. The stock trades at a P/E of 25.7, which is somewhat elevated, and exhibits moderate profitability with an ROE of 13.3%. Overall, the score reflects a balanced but unremarkable profile.

Generated by AI from the underlying QScore factors. Not investment advice.